Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Pension cash goes into PhysicsX round

3 min read
16:30UTC

British pension savings went into a British engineering-simulation company in a round priced by Singaporean state capital, the fourth investment from the British Growth Partnership.

TechnologyDeveloping
Key takeaway

The Bank joined a Temasek-led round using pension capital, its fourth British Growth Partnership position.

The British Business Bank put $25m into PhysicsX on 30 July, the fourth investment from British Growth Partnership Fund I since its £200m first close⁠1. Temasek, Singapore's state investment company, led the round, with M&G Investments also participating. PhysicsX builds simulation software for engineers designing physical products, and has doubled recognised revenue and passed 300 staff.

PhysicsX has appeared in this topic before. Temasek led a $300m Series C at a $2.4bn valuation in June, with no UK state vehicle contributing a pound. This time the Bank joined through the British Growth Partnership, which pools pension money and invests it alongside the Bank's own balance sheet. The partnership's other three positions are Wayve, Elliptic and Draig Therapeutics, and none has appeared in this topic before. Ian Connatty, the partnership's managing partner and the Bank's deputy chief investment officer, describes the fund as "created to connect pension funds with the UK's fastest growing companies".

That description names a real constraint rather than a slogan. A pension scheme cannot underwrite a single venture position on its own, because the diligence cost per pound invested is prohibitive and the trustees end up carrying exposure they have no way to price. Buying into a pooled vehicle that does the diligence once, across a portfolio, converts an unmanageable risk into a line item a trustee board can sign off. Whether British schemes take that conversion at scale is the question this cheque tests; PhysicsX would have priced with or without a British name on the round.

Deep Analysis

In plain English

PhysicsX is a British engineering-software company. It just raised money in a round led by Temasek, the Singaporean government's investment arm, with the asset manager M&G also taking part. The interesting part is where a small piece of that money came from: the British Business Bank's British Growth Partnership, a fund built specifically to let British pension schemes put money into fast-growing UK companies without each pension fund having to do that difficult, expensive work itself. This is only the fourth company the Partnership has backed since it started with £200m. In effect, ordinary British pension savings went into a British company, in a funding round mostly priced by Singaporean state money, through a vehicle designed to make that kind of investment simpler for pension trustees.

What could happen next?
  • Meaning

    The British Growth Partnership's co-investment model lets pension capital reach a $25m slice of a venture round it could not underwrite alone.

  • Risk

    Four positions since a £200m first close is a slow deployment pace for a fund meant to demonstrate pension co-investment at scale.

First Reported In

Update #14 · UKRI's sponsor department no longer exists

British Business Bank· 24 Aug 2026
Read original →
Causes and effects
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.